Nanda Nisha 4
4 · Loxo Oncology, Inc. · Filed Jan 2, 2019
Insider Transaction Report
Form 4
Nanda Nisha
Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-01-02+37,000→ 37,000 totalExercise: $139.77Exp: 2029-01-01→ Common Stock (37,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/48th of the total number of shares on February 2, 2019, then an additional 1/48th vests on each monthly anniversary thereafter, until such time as the option is 100% vested, subject to the reporting person's continued service through each vesting date.